Gary H. Hudes: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Kidney Cancer

Motzer, Robert J., Agarwal, Neeraj, Beard, Clair, Bolger, Graeme B., Boston, Barry, Carducci, Michael A., Choueiri, Toni K., Figlin, Robert A., Fishman, Mayer, Hancock, Steven L., Hudes, Gary R., Jona

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2009

Language:

english

File:

PDF, 504 KB

english, 2009

2

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M Bukowski, M Dror Michaelson, George Wilding, Gary R Hudes, Oliver Bolte, Robert J Motzer, Paul Bycott, Katherine F Liau, James Freddo, Peter C Trask, Sinil Kim, Brian I Rini

Journal:

The Lancet Oncology

Year:

2007

Language:

english

File:

PDF, 143 KB

english, 2007

3

Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma

Arthur S. Zbrozek,Gary Hudes,Donna Levy,Andrew Strahs…

Journal:

PharmacoEconomics

Year:

2010

Language:

english

File:

PDF, 144 KB

english, 2010

4

Immunohistochemical analysis of β-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy

Ranganathan, Sulabha, Salazar, Hernando, Benetatos, Christopher A., Hudes, Gary R.

Journal:

Year:

1997

Language:

english

File:

PDF, 309 KB

english, 1997

5

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

Gary R. Hudes, Stuart Lipsitz, Jean Grem, Mary Morrisey, Louis Weiner, John W. Kugler, Al Benson III

Journal:

Year:

1999

Language:

english

File:

PDF, 68 KB

english, 1999

6

Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins

Charles D. Smith, Jack T. Zilfou, Xinqun Zhang, Gary R. Hudes, Kenneth D. Tew

Journal:

Year:

1995

Language:

english

File:

PDF, 687 KB

english, 1995

7

Team-based learning in a medical gross anatomy and embryology course

Gary L. Nieder, Dean X. Parmelee, Adrienne Stolfi, Patricia D. Hudes

Journal:

Clinical Anatomy

Year:

2005

Language:

english

File:

PDF, 244 KB

english, 2005

8

Vinblastine and estramustine phosphate in metastatic renal cell carcinoma : A phase II trial of the Fox Chase Network

Naomi B. Haas, Bruce J. Giantonio, Samuel Litwin, Carl J. Minniti Jr., Stephen Fox, Gwen Yeslow, Robert Reilly, Kenneth Nahum, Richard Greenberg, Theresa Halbherr, Gary R. Hudes

Journal:

Year:

2003

Language:

english

File:

PDF, 70 KB

english, 2003

9

Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium : A trial of the Eastern Cooperative Oncology Group

Robert Dreicer, Judith Manola, Bruce J. Roth, William A. See, Steven Kuross, Martin J. Edelman, Gary R. Hudes, George Wilding

Journal:

Year:

2004

Language:

english

File:

PDF, 95 KB

english, 2004

10

Cranial nerve deficits in patients with metastatic prostate carcinoma : Clinical features and treatment outcomes

Raymond S. McDermott, Penny R. Anderson, Richard E. Greenberg, Barton N. Milestone, Gary R. Hudes

Journal:

Year:

2004

Language:

english

File:

PDF, 96 KB

english, 2004

11

Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference

Michael B. Atkins, Ronald M. Bukowski, Bernard J. Escudier, Robert A. Figlin, Gary H. Hudes, William G. Kaelin Jr, W. Marston Linehan, David F. McDermott, James W. Mier, Ivan Pedrosa, Brian I. Rini, S

Journal:

Year:

2009

Language:

english

File:

PDF, 104 KB

english, 2009

12

Targeting mTOR in renal cell carcinoma

Journal:

Year:

2009

Language:

english

File:

PDF, 153 KB

english, 2009

13

Analysis of PTEN and HIF-1α and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-α

Robert A. Figlin, Paul de Souza, David McDermott, Janice P. Dutcher, Anna Berkenblit, Alexandra Thiele, Mizue Krygowski, Andrew Strahs, Jay Feingold, Joseph Boni, Gary Hudes

Journal:

Year:

2009

Language:

english

File:

PDF, 324 KB

english, 2009

14

Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma

Jianming Pei, Madelyn M. Feder, Tahseen Al-Saleem, Zemin Liu, Angen Liu, Gary R. Hudes, Robert G. Uzzo, Joseph R. Testa

Journal:

Genes, Chromosomes and Cancer

Year:

2010

Language:

english

File:

PDF, 905 KB

english, 2010

15

PSA density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy

Steven R. Bonin, Benjamin W. Corn, Timothy Schultheiss, W.Robert Lee, Gary Hudes, Gerald E. Hanks

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1994

Language:

english

File:

PDF, 125 KB

english, 1994

16

Early stopping designs based on progression-free survival at an early time point in the initial cohort

Samuel Litwin, Yu-Ning Wong, Gary Hudes

Journal:

Statistics in Medicine

Year:

2007

Language:

english

File:

PDF, 164 KB

english, 2007

17

Phase II study of amonafide (Nafidamide, NSC 308847) in advanced colorectal cancer

Peter J. O'Dwyer, Anthony R. Paul, Gary R. Hudes, Judy Walczak, Robert F. Ozols, Robert L. Comis

Journal:

Investigational New Drugs

Year:

1991

Language:

english

File:

PDF, 185 KB

english, 1991

18

Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil

Gary R. Hudes, Frank LaCreta, Robert J. DeLap, Antonio J. Grillo-Lopez, Robert Catalano, Robert L. Comis

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1989

Language:

english

File:

PDF, 618 KB

english, 1989

19

Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside

Alxandre Hageboutros, Gary R. Hudes, James Brennan, Fran Green, John Hoffman, Frank P. LaCreta, Joseph Colofiore, Daniel S. Martin, Robert F. Ozols, Peter J. O'Dwyer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1996

Language:

english

File:

PDF, 691 KB

english, 1996

20

Phase II study of topotecan in metastatic hormone-refractory prostate cancer

Gary R. Hudes, Richard Kosierowski, Richard Greenberg, Harry E. Ramsey, Stephen C. Fox, Robert F. Ozols, Cecilia A. McAleer, Bruce J. Giantonio

Journal:

Investigational New Drugs

Year:

1995

Language:

english

File:

PDF, 562 KB

english, 1995

21

Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen

Louis M. Weiner, Gary R. Hudes, Joanne Kitson, Judy Walczak, Perry Watts, Samuel Litwin, Peter J. O'Dwyer

Journal:

Cancer Immunology, Immunotherapy

Year:

1993

Language:

english

File:

PDF, 750 KB

english, 1993

22

Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel

Tomasz M. Beer, Celestia S. Higano, Mansoor Saleh, Robert Dreicer, Gary Hudes, Joel Picus, Mark Rarick, Louis Fehrenbacher, Alison L. Hannah

Journal:

Investigational New Drugs

Year:

2007

Language:

english

File:

PDF, 118 KB

english, 2007

23

Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies

Janice P. Dutcher, Paul de Souza, David McDermott, Robert A. Figlin, Anna Berkenblit, Alexandra Thiele, Mizue Krygowski, Andrew Strahs, Jay Feingold, Gary Hudes

Journal:

Medical Oncology

Year:

2009

Language:

english

File:

PDF, 253 KB

english, 2009

24

Phase I trial of fluorouracil modulation by n-phosphonacetyl-l-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer

Alexandre Hageboutros, Gary R. Hudes, Fran Greene, Frank P. LaCreta, James Brennan, Peter J. O'Dwyer

Journal:

Investigational New Drugs

Year:

1997

Language:

english

File:

PDF, 46 KB

english, 1997

25

Toxicity and Response Evaluation of the Interferon Inducer Poly ICLC Administered at Low Dose in Advanced Renal Carcinoma and Relapsed or Refractory Lymphoma: A Report of Two Clinical Trials of the Eastern Cooperative Oncology Group

Bruce J. Giantonio, Howard Hochster, Ronald Blum, Peter H. Wiernik, Gary R. Hudes, John Kirkwood, Donald Trump, Martin M. Oken

Journal:

Investigational New Drugs

Year:

2001

Language:

english

File:

PDF, 33 KB

english, 2001

26

Signaling Inhibitors in the Treatment of Prostate Cancer

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 430 KB

english, 2002

27

Cloning and sequencing of human βIII-tubulin cDNA: induction of βIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents

Sulabha Ranganathan, Dwayne W Dexter, Christopher A Benetatos, Gary R Hudes

Journal:

Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression

Year:

1998

Language:

english

File:

PDF, 370 KB

english, 1998

28

Clinical Trial Experience With Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Gary R. Hudes, Anna Berkenblit, Jay Feingold, Michael B. Atkins, Brian I. Rini, Janice Dutcher

Journal:

Seminars in Oncology

Year:

2009

Language:

english

File:

PDF, 634 KB

english, 2009

29

A Wealth of New Options: A Case Presentation of the Management of Castration-Recurrent Prostate Cancer

Douglas F. Beach, Robert A. Somer, Jean Hoffman-Censits, Jianqing Lin, Yu-Ning Wong, Elizabeth Plimeck, Gary Hudes, David Vaughn, Guy T. Bernstein, Gloria J. Morris

Journal:

Seminars in Oncology

Year:

2012

Language:

english

File:

PDF, 304 KB

english, 2012

30

Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma

Robert J. Motzer, Gary Hudes, George Wilding, Lawrence H. Schwartz, Subramanian Hariharan, Susan Kempin, Rana Fayyad, Robert A. Figlin

Journal:

Clinical Genitourinary Cancer

Year:

2009

Language:

english

File:

PDF, 130 KB

english, 2009

31

Cutaneous metastases from genitourinary malignancies

Thomas J. Mueller, Hong Wu, Richard E. Greenberg, Gary Hudes, Neil Topham, Stuart R. Lessin, Robert G. Uzzo

Journal:

Year:

2004

Language:

english

File:

PDF, 172 KB

english, 2004

32

Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer

Evan Y. Yu, Christophe Massard, Mitchell E. Gross, Michael A. Carducci, Stephane Culine, Gary Hudes, Edwin M. Posadas, Cora N. Sternberg, George Wilding, Géralyn C. Trudel, Prashni Paliwal, Karim Fiza

Journal:

Year:

2011

Language:

english

File:

PDF, 480 KB

english, 2011

33

Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer

Naomi Haas, Bruce Roth, Carlos Garay, Gwen Yeslow, Michael Entmacher, Alan Weinstein, Andre Rogatko, James Babb, Carl Minnitti, David Flinker, Thomas Gillon, Gary Hudes

Journal:

Year:

2001

Language:

english

File:

PDF, 174 KB

english, 2001

34

Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer

Gary M Freedman, William G Negendank, Gary R Hudes, Andrew H Shaer, Gerald E Hanks

Journal:

Year:

1999

Language:

english

File:

PDF, 222 KB

english, 1999

35

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data

Karim Fizazi, Aurelie Le Maitre, Gary Hudes, William R Berry, W Kevin Kelly, Jean-Christophe Eymard, Christopher J Logothetis, Jean-Pierre Pignon, Stefan Michiels

Journal:

The Lancet Oncology

Year:

2007

Language:

english

File:

PDF, 175 KB

english, 2007

36

Serum Amino Acid Levels as a Biomarker for Renal Cell Carcinoma

Mustafa, Aladdin, Gupta, Sapna, Hudes, Gary R., Egleston, Brian L., Uzzo, Robert G., Kruger, Warren D.

Journal:

The Journal of Urology

Year:

2011

Language:

english

File:

PDF, 388 KB

english, 2011

37

Preclinical and clinical perspectives on the use of estramustine as an antimitotic drug

Kenneth D. Tew, Jenny P. Glusker, Beryl Hartley-Asp, Gary Hudes, Lisa A. Speicher

Journal:

Pharmacology & Therapeutics

Year:

1992

Language:

english

File:

PDF, 1.40 MB

english, 1992

38

Treatments for Improving Survival of Patients with Prostate Cancer

Alice K. David, Radhika Khwaja, Dr Gary R. Hudes

Journal:

Year:

2003

Language:

english

File:

PDF, 178 KB

english, 2003

39

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

Harmon, Charles S., DePrimo, Samuel E., Figlin, Robert A., Hudes, Gary R., Hutson, Thomas E., Michaelson, M. Dror, Négrier, Sylvie, Kim, Sindy T., Huang, Xin, Williams, J. Andrew, Eisen, Tim, Motzer,

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2014

Language:

english

File:

PDF, 294 KB

english, 2014

40

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

Hudes, Gary, Tagawa, Scott T., Whang, Young E., Qi, Ming, Qin, Xiang, Puchalski, Thomas A., Reddy, Manjula, Cornfeld, Mark, Eisenberger, Mario

Journal:

Investigational New Drugs

Year:

2013

Language:

english

File:

PDF, 208 KB

english, 2013

41

The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician

Uzzo, Robert G, Cairns, Paul, Al-Saleem, Tahseen, Hudes, Gary, Haas, Naomi, Greenberg, Richard E, Kolenko, Vladimir

Journal:

Urologic Clinics of North America

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

42

Prostate Specific Antigen Density is not an Independent Predictor of Response for Prostate Cancer Treated by Conformal Radiotherapy

Corn, Benjamin W., Hanks, Gerald E., Lee, Robert W., Bonin, Steven R., Hudes, Gary, Schultheiss, Timothy

Journal:

The Journal of Urology

Year:

1995

Language:

english

File:

PDF, 587 KB

english, 1995

43

PACLITAXEL AND DOCETAXEL IN PROSTATE CANCER

Obasaju, Coleman, Hudes, Gary R.

Journal:

Hematology/Oncology Clinics of North America

Year:

2001

Language:

english

File:

PDF, 1.26 MB

english, 2001

44

Sunitinib Efficacy Against Advanced Renal Cell Carcinoma

Motzer, Robert J., Michaelson, M. Dror, Rosenberg, Jonathan, Bukowski, Ronald M., Curti, Brendan D., George, Daniel J., Hudes, Gary R., Redman, Bruce G., Margolin, Kim A., Wilding, George

Journal:

The Journal of Urology

Year:

2007

Language:

english

File:

PDF, 133 KB

english, 2007

45

Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer

O'Dwyer, Peter J., Langer, Corey J., Walczak, Judy, Levy, Michael H., Padavic-Shaller, Kristin, Hudes, Gary R., Litwin, Sam, Comis, Robert L.

Journal:

European Journal of Cancer and Clinical Oncology

Year:

1991

Language:

english

File:

PDF, 705 KB

english, 1991

46

Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)

Meulenbeld, Hielke J., Bono, Johann S., Tagawa, Scott T., Whang, Young E., Li, Xiaoyun, Heath, Karl H., Zandvliet, Anthe S., Ebbinghaus, Scot W., Hudes, Gary R., Wit, Ronald

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 449 KB

english, 2013

47

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

Garcia, Jorge A., Hudes, Gary R., Choueiri, Toni K., Stadler, Walter M., Wood, Laura S., Gurtler, Jayne, Bhatia, Shailender, Joshi, Adarsh, Hozak, Rebecca R., Xu, Yihuan, Schwartz, Jonathan D., Thomps

Journal:

Year:

2014

Language:

english

File:

PDF, 306 KB

english, 2014

48

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Hudes, Gary, Carducci, Michael, Tomczak, Piotr, Dutcher, Janice, Figlin, Robert, Kapoor, Anil, Staroslawska, Elzbieta, Sosman, Jeffrey, McDermott, David, Bodrogi, István, Kovacevic, Zoran, Lesovoy, Vl

Journal:

Boston Medical and Surgical Journal

Year:

2007

Language:

english

File:

PDF, 252 KB

english, 2007

49

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma

Motzer, Robert J., Hutson, Thomas E., Hudes, Gary R., Figlin, Robert A., Martini, Jean-Francois, English, Patricia A., Huang, Xin, Valota, Olga, Williams, J. Andrew

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2014

Language:

english

File:

PDF, 283 KB

english, 2014

50

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Motzer, Robert J., Rini, Brian I., Bukowski, Ronald M., Curti, Brendan D., George, Daniel J., Hudes, Gary R., Redman, Bruce G., Margolin, Kim A., Merchan, Jaime R., Wilding, George, Ginsberg, Michelle

Journal:

JAMA The Journal of the American Medical Association

Year:

2006

Language:

english

File:

PDF, 407 KB

english, 2006